The targeted delivery system showed remarkable efficacy in preclinical trials. Tumor growth was significantly reduced, and the survival rate of the experimental subjects improved dramatically. Moreover, the treatment exhibited minimal side effects compared to traditional chemotherapy methods. These promising results suggest that nanoparticle-based drug delivery systems could revolutionize cancer treatment.
